The endocrine system is essentially the body’s long-distance communication network — peptide hormones travel through the bloodstream to deliver instructions to organs and tissues far from where they were produced. Researchers study endocrine peptide signaling to understand how the body regulates metabolism, hunger, growth, and stress response at the molecular level. Here’s a breakdown of the key peptide hormones most studied in endocrine research and what each one does.
Research Use Educational Framework
- Educational reference content only
- Structural stability awareness
- Environmental handling considerations
- Analytical quality and purity awareness
- Non-clinical research context
What Makes Peptides Central to Endocrine Research
Most people think of hormones as steroids — testosterone, estrogen, cortisol. But the majority of hormones in the human body are actually peptides. Insulin, glucagon, GLP-1, ghrelin, oxytocin, vasopressin, and growth hormone are all peptides. The endocrine system runs on peptide signaling far more than it runs on steroid hormones.
This is why peptide research and endocrine research overlap so heavily. When scientists study how the pancreas regulates blood sugar, they’re studying peptide hormones like insulin and glucagon. When they study hunger and satiety, they’re studying ghrelin and GLP-1. When they study growth and tissue repair, they’re studying growth hormone and IGF-1. Peptides aren’t a niche subset of endocrine biology — they are endocrine biology.
GLP-1 — The Gut Hormone Driving Metabolic Research
GLP-1 (Glucagon-Like Peptide-1) is secreted by L-cells in the small intestine in response to food intake. It signals the pancreas to release insulin, suppresses glucagon (which would otherwise raise blood sugar), slows gastric emptying, and sends satiety signals to the hypothalamus in the brain.
Natural GLP-1 has a half-life of just 1-2 minutes — it’s rapidly degraded by the enzyme DPP-4. This is the fundamental limitation that GLP-1 receptor agonist research seeks to overcome. Semaglutide, Tirzepatide, and Retatrutide are all synthetic GLP-1 analogs engineered to resist DPP-4 degradation, extending their activity from minutes to days.
The explosion of GLP-1 research over the past decade has been driven by clinical findings showing that GLP-1 receptor activation produces significant metabolic effects beyond blood sugar control — including cardiovascular protection, neurological effects, and kidney function improvements currently being characterized in ongoing research.
For a deep dive into the GLP-1 mechanism, see our article How GLP-1 Peptides Work. For the full compound comparison, see Tirzepatide vs Semaglutide.
Ghrelin — The Hunger Hormone & Its Research Implications
Ghrelin is a peptide hormone produced primarily in the stomach. It’s the only known circulating hormone that stimulates appetite — earning it the nickname “the hunger hormone.” Ghrelin levels rise before meals and fall after eating, acting as a biological signal that it’s time to eat.
Beyond hunger signaling, ghrelin also stimulates growth hormone release from the pituitary gland. This dual role — appetite regulation and growth hormone axis activation — makes ghrelin relevant to two major areas of endocrine research simultaneously.
Researchers study ghrelin for several reasons. Understanding how ghrelin signaling works is critical to understanding appetite dysregulation in obesity and metabolic disease. Ghrelin receptor agonists (compounds that mimic ghrelin’s effects) are studied for their ability to stimulate growth hormone secretion — this is the basis for growth hormone releasing peptides (GHRPs) like GHRP-6, which are studied as research tools for examining the growth hormone axis.
The relationship between ghrelin and GLP-1 is also an active research area — they essentially work in opposition, with ghrelin stimulating appetite and GLP-1 suppressing it. Understanding how these two peptide systems interact is central to metabolic research.
Growth Hormone Peptides — The GH Axis in Research
Growth hormone (GH) is a peptide hormone produced by the pituitary gland that regulates growth, metabolism, and body composition. Its downstream effects are largely mediated by IGF-1, which is produced in the liver in response to GH signaling.
Researchers study the growth hormone axis through several classes of peptides. Growth Hormone Releasing Hormones (GHRHs) like CJC-1295 stimulate the pituitary to produce and release growth hormone. Growth Hormone Releasing Peptides (GHRPs) like GHRP-6 and Ipamorelin act on ghrelin receptors in the pituitary to stimulate GH release through a separate pathway. These two classes are often studied together because they work synergistically — combined administration produces significantly greater GH release than either alone.
IGF-1 LR3 sits downstream of this system, acting directly on muscle and tissue cells rather than stimulating GH release. Researchers use it to study the end-organ effects of growth hormone signaling without the upstream variability introduced by GH secretion dynamics.
The growth hormone axis is one of the most studied systems in endocrine peptide research because of its broad influence on body composition, metabolism, aging, and tissue repair.
Why Endocrine Peptide Research Is Expanding
First, the success of GLP-1 receptor agonists as approved medications has validated the entire approach of targeting peptide hormone receptors therapeutically. Semaglutide and Tirzepatide achieving blockbuster drug status has directed enormous research investment toward finding the next generation of peptide-based metabolic therapies — including Retatrutide’s triple agonist approach.
Second, advances in peptide synthesis and stability engineering have made it possible to design peptides that resist enzymatic degradation and maintain receptor activity for days or weeks rather than minutes. This has opened research possibilities that simply didn’t exist a decade ago.
Third, the discovery that peptide hormone systems are far more interconnected than previously understood — GLP-1 affecting cardiovascular function, ghrelin affecting the immune system, growth hormone influencing cognition — has expanded the research agenda well beyond traditional endocrinology.
BioStrata Research supplies research-grade GLP-1 compounds including Semaglutide, Tirzepatide, and Retatrutide. Browse our Metabolic Research catalog for full product details and COA documentation.
FAQ — Hormonal & Endocrine Peptide Research
What are peptide hormones? Peptide hormones are signaling molecules made from amino acid chains that travel through the bloodstream to regulate biological processes in distant organs and tissues. Most hormones in the human body are peptides — including insulin, GLP-1, ghrelin, growth hormone, and oxytocin.
What is GLP-1 and why is it important in endocrine research? GLP-1 is a gut hormone that regulates insulin release, appetite, and gastric emptying. Synthetic GLP-1 receptor agonists like Semaglutide and Tirzepatide have become among the most studied compounds in metabolic medicine. See our full guide: What Are GLP-1 Peptides?
What is ghrelin and how does it relate to GLP-1? Ghrelin is the primary appetite-stimulating hormone, produced in the stomach. GLP-1 is the primary satiety hormone, produced in the gut. They work in opposition. Understanding how these two peptide systems interact is central to metabolic research and obesity biology.
What are growth hormone releasing peptides? GHRPs like GHRP-6 and Ipamorelin stimulate pituitary release of growth hormone by acting on ghrelin receptors. They’re studied in combination with GHRHs like CJC-1295 to examine growth hormone axis dynamics and downstream IGF-1 effects.
Where can I explore GLP-1 and metabolic research compounds? BioStrata Research supplies Semaglutide, Tirzepatide, and Retatrutide as research-grade compounds with full third-party COA documentation. Browse our Metabolic Research catalog.
- CONTINUE LEARNING
Explore Related Peptide Topics
Continue building your understanding by exploring related foundational peptide topics.